CONTACT PERSON: Per Christian Sontum
PHONE: +47 472 61 042
WEB SITE: https://www.phoenixsolutions.no/
Founded in: 2012
Number of employees: 3
CEO: Per Christian Sontum
Phoenix Solutions AS is a Norwegian biotech company spun out from GE Healthcare in 2013, currently developing a technology platform for targeted drug delivery – Acoustic Cluster Therapy (ACT®). ACT® is a unique approach to ultrasound (US) mediated, targeted drug delivery – capable of enhancing significantly the clinical utility of a wide range of therapeutic molecules and nano-drugs for a wide range of clinical indications.
ACT®`s primary mode of action is in defeating the vascular barrier and enhancing extravasation for greater distribution and uptake of a co-administered drug to the targeted tissue, with resulting increased efficacy and/or reduction in toxicity.
ACT® is a physical approach all together and rests on the interaction between US and a unique formulation enabling in situgeneration and local deposition microbubbles in targeted tissues. All constituents in the ACT® formulation are chemically and biologically inert; there`s no active biochemistry and no metabolism involved – the technology rests fully on the generation of biomechanical effects in the vascular compartment.